Allan Collings
Founder at ACM Properties Ltd.
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Paul Cataford | M | 60 | 2 years | |
| Neil E. Reiner | M | - |
Indel Therapeutics, Inc.
 Indel Therapeutics, Inc. BiotechnologyHealth Technology Indel Therapeutics, Inc. operates as a biopharmaceutical company. It focuses on the discovery, development, and commercialization of antibiotics to address the health crisis caused by antibiotics resistance. The firm’s programs are based on Indel's paradigm-changing antimicrobial drug discovery platform that has opened drug targets for the treatment of bacterial and parasitic infections, and potentially, fungal and viral infections. The company was founded by Malcolm C. Kendall in 2008 and is headquartered in Vancouver, Canada.^ ^ | - |
| Chad Mallow | M | - |
ACM Advisors Ltd.
 ACM Advisors Ltd. Investment ManagersFinance ACM Advisors Ltd. is a Canadian Alternative Asset Manager headquartered in Vancouver, British Columbia. The firm was founded in 1992 by Gordon Allan and Allan Collings. They were acquired by EQB, Inc. EQB, Inc. (TSE: EQB) in 2023. The firm creates, structures, and manages pooled Canadian commercial mortgage funds. ACM Advisors is a signatory to the UN Principles for Responsible Investment (UNPRI). | 20 years |
| Ishbel Buchan | F | - |
ACM Advisors Ltd.
ACM Advisors Ltd. Investment ManagersFinance ACM Advisors Ltd. is a Canadian Alternative Asset Manager headquartered in Vancouver, British Columbia. The firm was founded in 1992 by Gordon Allan and Allan Collings. They were acquired by EQB, Inc. EQB, Inc. (TSE: EQB) in 2023. The firm creates, structures, and manages pooled Canadian commercial mortgage funds. ACM Advisors is a signatory to the UN Principles for Responsible Investment (UNPRI). | 13 years |
| Jordan Hearne | M | - |
ACM Advisors Ltd.
ACM Advisors Ltd. Investment ManagersFinance ACM Advisors Ltd. is a Canadian Alternative Asset Manager headquartered in Vancouver, British Columbia. The firm was founded in 1992 by Gordon Allan and Allan Collings. They were acquired by EQB, Inc. EQB, Inc. (TSE: EQB) in 2023. The firm creates, structures, and manages pooled Canadian commercial mortgage funds. ACM Advisors is a signatory to the UN Principles for Responsible Investment (UNPRI). | 8 years |
| Sophia Langlois | F | - | 3 years | |
| Roger Léger | M | - |
Indel Therapeutics, Inc.
Indel Therapeutics, Inc. BiotechnologyHealth Technology Indel Therapeutics, Inc. operates as a biopharmaceutical company. It focuses on the discovery, development, and commercialization of antibiotics to address the health crisis caused by antibiotics resistance. The firm’s programs are based on Indel's paradigm-changing antimicrobial drug discovery platform that has opened drug targets for the treatment of bacterial and parasitic infections, and potentially, fungal and viral infections. The company was founded by Malcolm C. Kendall in 2008 and is headquartered in Vancouver, Canada.^ ^ | - |
| Daryl Musselman | M | 57 | 4 years | |
| Gordon Bruce Allan | M | - |
ACM Advisors Ltd.
ACM Advisors Ltd. Investment ManagersFinance ACM Advisors Ltd. is a Canadian Alternative Asset Manager headquartered in Vancouver, British Columbia. The firm was founded in 1992 by Gordon Allan and Allan Collings. They were acquired by EQB, Inc. EQB, Inc. (TSE: EQB) in 2023. The firm creates, structures, and manages pooled Canadian commercial mortgage funds. ACM Advisors is a signatory to the UN Principles for Responsible Investment (UNPRI). | 32 years |
| Graham Allan Collings | M | - |
ACM Advisors Ltd.
ACM Advisors Ltd. Investment ManagersFinance ACM Advisors Ltd. is a Canadian Alternative Asset Manager headquartered in Vancouver, British Columbia. The firm was founded in 1992 by Gordon Allan and Allan Collings. They were acquired by EQB, Inc. EQB, Inc. (TSE: EQB) in 2023. The firm creates, structures, and manages pooled Canadian commercial mortgage funds. ACM Advisors is a signatory to the UN Principles for Responsible Investment (UNPRI). | 17 years |
| Jordan Ross | M | - |
ACM Advisors Ltd.
ACM Advisors Ltd. Investment ManagersFinance ACM Advisors Ltd. is a Canadian Alternative Asset Manager headquartered in Vancouver, British Columbia. The firm was founded in 1992 by Gordon Allan and Allan Collings. They were acquired by EQB, Inc. EQB, Inc. (TSE: EQB) in 2023. The firm creates, structures, and manages pooled Canadian commercial mortgage funds. ACM Advisors is a signatory to the UN Principles for Responsible Investment (UNPRI). | 11 years |
| Greg Martin | M | - |
ACM Advisors Ltd.
ACM Advisors Ltd. Investment ManagersFinance ACM Advisors Ltd. is a Canadian Alternative Asset Manager headquartered in Vancouver, British Columbia. The firm was founded in 1992 by Gordon Allan and Allan Collings. They were acquired by EQB, Inc. EQB, Inc. (TSE: EQB) in 2023. The firm creates, structures, and manages pooled Canadian commercial mortgage funds. ACM Advisors is a signatory to the UN Principles for Responsible Investment (UNPRI). | 8 years |
| Kirk Livingston | M | - | 5 years | |
| Christopher C. Clulow | M | 52 | 3 years | |
| Richard J. White | M | 82 |
Indel Therapeutics, Inc.
Indel Therapeutics, Inc. BiotechnologyHealth Technology Indel Therapeutics, Inc. operates as a biopharmaceutical company. It focuses on the discovery, development, and commercialization of antibiotics to address the health crisis caused by antibiotics resistance. The firm’s programs are based on Indel's paradigm-changing antimicrobial drug discovery platform that has opened drug targets for the treatment of bacterial and parasitic infections, and potentially, fungal and viral infections. The company was founded by Malcolm C. Kendall in 2008 and is headquartered in Vancouver, Canada.^ ^ | - |
| Patrick Scannon | M | 76 |
Indel Therapeutics, Inc.
Indel Therapeutics, Inc. BiotechnologyHealth Technology Indel Therapeutics, Inc. operates as a biopharmaceutical company. It focuses on the discovery, development, and commercialization of antibiotics to address the health crisis caused by antibiotics resistance. The firm’s programs are based on Indel's paradigm-changing antimicrobial drug discovery platform that has opened drug targets for the treatment of bacterial and parasitic infections, and potentially, fungal and viral infections. The company was founded by Malcolm C. Kendall in 2008 and is headquartered in Vancouver, Canada.^ ^ | - |
| George Rubin | M | - | 4 years | |
| Kent Thexton | M | 61 | 2 years | |
| Irwin Kuntz | M | - |
Indel Therapeutics, Inc.
Indel Therapeutics, Inc. BiotechnologyHealth Technology Indel Therapeutics, Inc. operates as a biopharmaceutical company. It focuses on the discovery, development, and commercialization of antibiotics to address the health crisis caused by antibiotics resistance. The firm’s programs are based on Indel's paradigm-changing antimicrobial drug discovery platform that has opened drug targets for the treatment of bacterial and parasitic infections, and potentially, fungal and viral infections. The company was founded by Malcolm C. Kendall in 2008 and is headquartered in Vancouver, Canada.^ ^ | - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Darren Z. Ready | M | 51 | - | |
| John William Greenslade | M | 75 |
University of British Columbia
| 9 years |
| Ossama R. Hassanein | M | - |
University of British Columbia
| 4 years |
| Ethan Hugh | M | - | 3 years | |
| Jack H. L. Miller | M | - |
University of British Columbia
| 6 years |
| Thomas Beattie | M | - |
University of British Columbia
| 5 years |
| James Robertson | M | - |
University of British Columbia
| 6 years |
| David Nairne | M | - |
University of British Columbia
| 5 years |
| David de Witt | M | 71 |
University of British Columbia
| 7 years |
| Glenn Yeadon | M | 73 |
University of British Columbia
| 5 years |
| P. Reifel | M | 72 |
University of British Columbia
| 6 years |
| Wendy Louise Bach | F | 69 | - | |
| Michael Edward O'Connor | M | - |
University of British Columbia
| 4 years |
| Gordon William Blankstein | M | 73 |
University of British Columbia
| 7 years |
| William Murdoch | M | - | 7 years | |
| Ronald Tysoe | M | 71 |
University of British Columbia
| 5 years |
| David Schwartz | M | - |
University of British Columbia
| 5 years |
| Gordon Ellis | M | 77 |
University of British Columbia
| 6 years |
| Douglas Eacrett | M | 78 |
University of British Columbia
| 6 years |
| Murray L. Swales | M | 73 |
University of British Columbia
| 4 years |
| Bob Bebluk | M | - |
University of British Columbia
| 6 years |
| Georgios Polyhronopoulos | M | 66 |
University of British Columbia
| 4 years |
| Robin Hutchison | M | 68 |
University of British Columbia
| 4 years |
| Tom Richards | M | - |
University of British Columbia
| 3 years |
| Terry Krepiakevich | M | 71 |
University of British Columbia
| 4 years |
| Lam Sin Lai Tsui | M | 69 |
University of British Columbia
| 4 years |
| James Albert Turner | M | 75 |
University of British Columbia
| 4 years |
| Richard P. Schutte | M | - |
University of British Columbia
| 4 years |
| Mark Ralston | M | 71 |
University of British Columbia
| 4 years |
| Howie Young | M | - |
University of British Columbia
| 4 years |
| David A. Yeager | M | - |
University of British Columbia
| 4 years |
| Richard E. Fortescue | M | 70 |
University of British Columbia
| 4 years |
| David Lyall | M | 68 |
University of British Columbia
| 4 years |
| Karen L. Danielson | F | - |
University of British Columbia
| 4 years |
| David Christie | M | 77 |
University of British Columbia
| 4 years |
| Douglas Buchanan | M | - |
University of British Columbia
| 4 years |
| Ferdinand Lobkowicz | M | - |
University of British Columbia
| 4 years |
| Gordon R. Osinchuk | M | - |
University of British Columbia
| 4 years |
| Ron Anderson | M | - |
University of British Columbia
| 4 years |
| David L. Adderley | M | 68 |
University of British Columbia
| 4 years |
| Dae-Ryun Jang | M | 67 |
University of British Columbia
| 4 years |
| Daniel B. Gleadle | M | 72 |
University of British Columbia
| 3 years |
| Charles MaLette | M | 78 |
University of British Columbia
| 4 years |
| Lee Herbert | M | 71 |
University of British Columbia
| 4 years |
| Robert Waters | M | 73 |
University of British Columbia
| 4 years |
| Gary Moore | M | - |
University of British Columbia
| 4 years |
| Andre J. Audet | M | - |
University of British Columbia
| 4 years |
| Carl G. Verley | M | - |
University of British Columbia
| 4 years |
| Guy Gordon | M | - |
University of British Columbia
| 4 years |
| Andrew William Gourlay | M | - |
University of British Columbia
| 4 years |
| Robert George Lewis | M | - |
University of British Columbia
| 3 years |
| Rajinder Chowdhry | M | 71 |
University of British Columbia
| 4 years |
| Richard Alfred Grafton | M | 70 |
University of British Columbia
| 4 years |
| Ian Power | M | - |
University of British Columbia
| 4 years |
| Arthur James Mcfaull | M | - |
University of British Columbia
| 4 years |
| Frederic G. Hewett | M | - |
University of British Columbia
| 4 years |
| Dave Jiles | M | - |
University of British Columbia
| 4 years |
| Yvan Joseph Bourdeau | M | - |
University of British Columbia
| 2 years |
| Ross Beaty | M | 72 |
University of British Columbia
| 4 years |
| Gregory D. Aasen | M | 68 |
University of British Columbia
| 4 years |
| Donald Gee | M | 73 |
University of British Columbia
| 4 years |
| Glen MacDonald | M | 75 |
University of British Columbia
| 4 years |
| Greg Peet | M | 70 |
University of British Columbia
| 5 years |
| Ross A. Mitchell | M | 74 |
University of British Columbia
| 4 years |
| J. Peter Campbell | M | - |
University of British Columbia
| 4 years |
| Bryan T. Nethery | M | - |
University of British Columbia
| 4 years |
| Peter M. Holbek | M | - |
University of British Columbia
| 6 years |
| Beverley Briscoe | F | 69 |
University of British Columbia
| 4 years |
| Dickson Hall | M | 72 |
University of British Columbia
| 4 years |
| Ronald J. Zokol | M | 74 |
University of British Columbia
| 4 years |
| Neville Desmond Smith | M | 71 |
University of British Columbia
| 4 years |
| Deborah E. Fortescue-Merrin | F | 68 |
University of British Columbia
| 4 years |
| Chris White | M | - |
University of British Columbia
| 4 years |
| William R. LeClair | M | 71 |
University of British Columbia
| 4 years |
| Martin John Gardner Glynn | M | 72 |
University of British Columbia
| 2 years |
| Bill Morton | M | 74 |
University of British Columbia
| 3 years |
| William Pearson | M | - |
University of British Columbia
| 4 years |
| Wan H. Jung | M | 67 |
University of British Columbia
| 4 years |
| Jean-Pierre Soublière | M | - |
University of British Columbia
| 2 years |
| Ronald Ewing | M | - |
University of British Columbia
| 4 years |
| John Blanchflower | M | - |
University of British Columbia
| 4 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| Canada | 100 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Allan Collings
- Personal Network
